Indian Pharma giant Dr. Reddy's Lab has received final approval from the USFDA to market Alendronate sodium trihydrate tablets. Following generic players have got final approval to market this blockbuster drug.
1) Teva
2) Barr
3) Mylan
4) Watson
5) Cobalt
7) Apotex
8) Genpharm
9) Dr. Reddy
10) Aurbindo
11) Ivax (Tentative approval)
Earlier, Teva and Barr got 180 days exclusivity, which started on Feb 6, 2008 and expired on August 3, 2008. Most of the generic player (excluding Barr and Teva) got final approval on August 4, 2008.
No comments:
Post a Comment